Revenue
2015
2016
2017
2018
2019
2020
2021
2022
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ¥3.32T | ¥2.74T | ¥2.10T | ¥2.96T | ¥2.88T | ¥2.36T | ¥1.93T | ¥2.02T |
| Research & development | ¥12.77B | ¥11.48B | ¥10.09B | ¥9.45B | ¥8.00B | ¥6.42B | ¥5.94B | ¥5.65B |
| Operating expenses | ¥3.24T | ¥2.65T | ¥2.09T | ¥2.87T | ¥2.80T | ¥2.29T | ¥1.85T | ¥1.96T |
| Operating income | ¥75.83B | ¥94.63B | ¥13.67B | ¥86.52B | ¥82.56B | ¥71.47B | ¥77.19B | ¥56.82B |
| EBITDAderived | ¥185.74B | ¥210.31B | ¥121.13B | ¥196.16B | ¥192.91B | ¥186.78B | ¥185.62B | ¥153.28B |
| Net income | ¥66.15B | ¥71.97B | ¥33.44B | ¥57.52B | ¥61.71B | ¥51.24B | ¥46.67B | ¥32.51B |
| Basic EPSper diluted share | CN¥0.55 | CN¥0.59 | CN¥0.28 | CN¥0.48 | CN¥0.51 | CN¥0.42 | CN¥0.39 | CN¥0.27 |
| Diluted EPSper diluted share | CN¥0.55 | CN¥0.59 | CN¥0.28 | CN¥0.48 | CN¥0.51 | CN¥0.42 | CN¥0.39 | CN¥0.27 |